Portal de Periódicos da CAPES

Antiglycative and neuroprotective activity of colon‐derived polyphenol catabolites

2011; Wiley; Volume: 55; Issue: S1 Linguagem: Inglês

10.1002/mnfr.201000525

1613-4133

Elena Verzelloni, Claudia Pellacani, Davide Tagliazucchi, Sara Tagliaferri, Luca Calani, Lucio G. Costa, Furio Brighenti, Gina Borges, Alan Crozier, Angela Conte, Daniele Del Rio,

Ginkgo biloba and Cashew Applications

Dietary flavonoids and allied phenolic compounds are thought to be beneficial in the control of diabetes and its complications, because of their ability to inhibit oxidative stress, protein glycation and to act as neuroprotectants. Following ingestion by humans, polyphenolic compounds entering the large intestine undergo extensive metabolism by interaction with colonic microbiota and it is metabolites and catabolites of the parent compounds that enter the circulatory system. The aim of this study was to investigate the inhibitory activity of some colonic microbiota-derived polyphenol catabolites against advanced glycation endproducts formation in vitro and to determine their ability, at physiological concentrations, to counteract mild oxidative stress of cultured human neuron cells.This study demonstrated that ellagitannin-derived catabolites (urolithins and pyrogallol) are the most effective antiglycative agents, whereas chlorogenic acid-derived catabolites (dihydrocaffeic acid, dihydroferulic acid and feruloylglycine) were most effective in combination in protecting neuronal cells in a conservative in vitro experimental model.Some polyphenolic catabolites, generated in vivo in the colon, were able in vitro to counteract two key features of diabetic complications, i.e. protein glycation and neurodegeneration. These observations could lead to a better control of these events, which are usually correlated with hyperglycemia.